ReproSource: Quest Diagnostics (DGX) Acquires ReproSource
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has acquired ReproSource, a national leader in specialty fertility diagnostic services.
Read full article »
ReproSource is a clinical laboratory that provides pregnancy loss assessments and diagnostic services for fertility patients.
Read more